Impact factor (WEB OF SCIENCE - Clarivate)

2 year: 7.664 | 5 year: 7.127

Ongoing Research Themes

What are the risk factors for death among children with pneumonia in low- and middle-income countries? A systematic review

Chris Wilkes1, Mohamed Bava1, Hamish R Graham1,2*, Trevor Duke1,2*; ARI Review group

1 Murdoch Children’s Research Institution, Royal Children’s Hospital, Parkville, Victoria, Australia
2 Department of Paediatrics, University of Melbourne, Royal Children’s Hospital, Parkville, Victoria, Australia
* Joint senior authorship.

DOI: 10.7189/jogh.13.05003




Knowledge of the risk factors for and causes of treatment failure and mortality in childhood pneumonia is important for prevention, diagnosis, and treatment at an individual and population level. This review aimed to identify the most important risk factors for mortality among children aged under ten years with pneumonia.


We systematically searched MEDLINE, EMBASE, and PubMed for observational and interventional studies reporting risk factors for mortality in children (aged two months to nine years) in low- and middle-income countries (LMICs). We screened articles according to specified inclusion and exclusion criteria, assessed risk of bias using the EPHPP framework, and extracted data on demographic, clinical, and laboratory risk factors for death. We synthesized data descriptively and using Forest plots and did not attempt meta-analysis due to the heterogeneity in study design, definitions, and populations.


We included 143 studies in this review. Hypoxaemia (low blood oxygen level), decreased conscious state, severe acute malnutrition, and the presence of an underlying chronic condition were the risk factors most strongly and consistently associated with increased mortality in children with pneumonia. Additional important clinical factors that were associated with mortality in the majority of studies included particular clinical signs (cyanosis, pallor, tachypnoea, chest indrawing, convulsions, diarrhoea), chronic comorbidities (anaemia, HIV infection, congenital heart disease, heart failure), as well as other non-severe forms of malnutrition. Important demographic factors associated with mortality in the majority of studies included age <12 months and inadequate immunisation. Important laboratory and investigation findings associated with mortality in the majority of studies included: confirmed Pneumocystis jirovecii pneumonia (PJP), consolidation on chest x-ray, pleural effusion on chest x-ray, and leukopenia. Several other demographic, clinical and laboratory findings were associated with mortality less consistently or in a small numbers of studies.


Risk assessment for children with pneumonia should include routine evaluation for hypoxaemia (pulse oximetry), decreased conscious state (e.g. AVPU), malnutrition (severe, moderate, and stunting), and the presence of an underlying chronic condition as these are strongly and consistently associated with increased mortality. Other potentially useful risk factors include the presence of pallor or anaemia, chest indrawing, young age (<12 months), inadequate immunisation, and leukopenia.

Print Friendly, PDF & Email

Knowledge of the risk factors for and causes of treatment failure and mortality in childhood pneumonia is important for prevention, diagnosis, and treatment at an individual and population level [1]. From a preventive perspective it enables health care workers (HCWs) and public health workers to identify individuals and populations with modifiable risk factors for poor outcomes (e.g. malnutrition) and intervene. From a diagnosis and treatment perspective, risk-stratification is critical to ensure the right patients are prioritised for the right care (e.g. who needs admission vs home treatment) and encourages the most efficient use of available resources (e.g. money, staff time, medication).

One example of risk stratification is the World Health Organization (WHO) guidelines for childhood pneumonia which use known clinical risk factors to stratify patients into “severe” and “non-severe” classifications and provide practical guidance on referral and treatment [24]. In the WHO guidelines, stratification is based on presence or absence of central cyanosis, hypoxaemia (defined as oxygen saturations less than 90%), severe respiratory distress, and general danger signs including inability to drink or breastfeed, lethargy or unconsciousness, or convulsions [2].

The potential value of understanding risk factors goes beyond their utility in standardised clinical guidelines, offering opportunity to better understand population vulnerabilities and inform responses both at an individual patient and population level. The unacceptably high mortality rates among children with pneumonia (including those without signs of WHO severe pneumonia) makes understanding these risk factors even more important – particularly for children in low- and middle-income countries (LMICs) where the greatest burden lies [5]. Recent developments in clinical medicine and public health now offer a greater range of possible demographic, clinical, aetiological, and laboratory risk factors to consider [5]. While the advent of widespread vaccination against Streptococcus pneumoniae and Haemophilus influenzae type B (Hib), previously two of the most common pathogenic causes of pneumonia, has changed the aetiology of pneumonia and potentially further altered the causes of treatment failure and mortality [6].

This review aimed to identify clinical, demographic, and investigation findings that are associated with treatment failure or mortality in children (aged two months to nine years) with pneumonia in LMICs.


We conducted a systematic search of medical databases MEDLINE, EMBASE, and PubMed (for recent studies not yet indexed on MEDLINE) for studies reporting on factors associated with child pneumonia mortality (August 30, 2020). We mapped search terms to medical subject headings where possible, using Boolean operators to combine searches into our final systematic search query. We used synonyms of “pneumonia”, “mortality”, and “child” to target our search strategy, with oversight from an experienced Health Service Librarian to ensure all relevant papers were identified. We also searched reference lists of all included references for eligible studies. Additional methodological detail, including the Medline search strategy, information sources and data collection processes are included in Text S1 in the Online Supplementary Document.

Assessment of study eligibility

We included observational and interventional studies from LMICs involving children aged 28 days to nine years with pneumonia and reporting data on risk factors for death. We focussed on studies published since 2010 to reflect current aetiology and diagnostic / treatment approaches and limited to English language. We included studies involving children older than five years of age as this is an important neglected child population but expected most studies to focus on the traditional under five-year population. Two reviewers (CW and MB) independently screened the titles and abstracts of all returned studies, obtained full text for studies that were screened in by either reviewer, then independently assessed them for inclusion. We resolved disagreements by discussion and, where appropriate, review by a third reviewer (HG). None of the reviewers were blind to the journal titles, study authors, or affiliated institutions.

Data management, extraction, and synthesis

Two reviewers (CW and MB) independently extracted data from each eligible study and entered data into standardised data extraction spreadsheet using Excel (Microsoft, Redmond, US). We resolved disagreements by discussion and contacted study authors where appropriate to resolve uncertainties. We extracted data on study design, context, population, mortality and treatment failure rates, and associations with various risk factors (categorised as demographic, clinical, and laboratory risk factors).

We categorised context, population and outcome data, then qualitatively synthesised results to determine the consistently reported risk factors for mortality in children with pneumonia including summary data on odds ratios and case fatality rates. To account for the possibility of type 1 or type 2 errors clouding the true significance of factors that were only analysed in a small number of studies, we disaggregated results to show which factors were examined in at least four studies. We focus our reporting on those factors that have been studied in at least four studies and found to be universally (in all studies) or consistently (in the majority of studies) associated with mortality.

We reported crude and adjusted estimates of associations with mortality, as per individual studies, recognising that there was variable use of odds ratios, risk ratios (relative risk), and hazards ratios. To enable comparison between studies we summarised crude estimates (usually odds ratio) for the risk factors identified to be most consistently and strongly associated with death reporting them as median and range. We did not attempt meta-analysis as our primary goal was to understand treatment outcomes with respect to a range of risk factors with variability in definition and heterogeneity in population and context. We did not attempt quantitative examination of heterogeneity or certainty but reported all outcomes of interest by individual study in supplemental material for completeness and transparency.

In addition to mortality as a hard endpoint of treatment failure, we also reviewed other treatment failure endpoints (variously defined as clinical deterioration requiring a change in management, or persistence of particular symptoms), hypoxaemia (an objective sign of respiratory failure), and the need for high dependency unit / intensive care unit (HDU / ICU) admission.

Assessment of study quality and risk of bias

We assessed the quality and risk of bias of all included studies by using the Effective Public Health Practice Project (EPHPP) Quality Assessment Tool [7,8]. Two reviewers (CW and MB) independently rated studies as strong, moderate, or weak with respect to selection bias, study design, confounders, blinding, data collection method, withdrawals and dropouts, and a global rating. Where disagreements occurred, a third reviewer (HG) carried out a final assessment.

We report our findings according to PRISMA and SWiM standards [9,10].


A total of 8492 references were retrieved through the search, and two additional relevant papers were identified on review of references. After duplicates were removed 5687 references were screened, including full text screening of 283 publications. We excluded 140 papers on full text review (Text S2 in the Online Supplementary Document), primarily due to lack of relevant data on risk factors (n = 59) or not relating to children with pneumonia (n = 50) (Figure 1). We included 143 studies in qualitative synthesis [11153].

Figure 1.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram [9].

Characteristics of studies

Included study details and participant characteristics are reported in Table 1 and details are presented in Table S4 in the Online Supplementary Document. Papers were included from all WHO regions and all World Bank income levels, including 36 (25%) studies involving low-income countries (LICs), 70 (49%) LMICs, and 53 (37%) upper-middle income countries (UMICs). One hundred and thirty-six (95%) studies were observational, including prospective and retrospective cohort studies, cross-sectional studies, case-control studies, surveillance studies, with seven (5%) interventional studies. Study quality was typically low to moderate with seven (5%) studies rating as “strong” on EPHPP (Table S1 in the Online Supplementary Document). Thirty-five (25%) studies addressed risk factors for mortality in childhood pneumonia as their primary aim.

Table 1.  Characteristics of included studies and participant characteristics

WordPress Tables Plugin

CAP – community acquired pneumonia, ICU – intensive care unit, MV – mechanical ventilation, PICU – paediatric intensive care unit, IMSS – Instituto Mexicano de Seguro Social (eng. Mexican Institute of Social Security)

*These studies had risk factor identification as an explicit objective.


Number of child participants in each study ranged from 40 to 113 154 (median = 519). Median age ranged from three to 65 months and most studies (n = 83 / 92, 90%) that reported the participant sex included more males than females (percentage of males ranged from 44.50% to 71.70%). Vaccination status was reported in 23 (16%) studies, with 52% to 97% of children fully vaccinated according to national schedules. Many studies were conducted prior to introduction of Hib or pneumococcal conjugate vaccine (PCV) and there was enormous variability in PCV and Hib vaccination status (from 0.00 to 99.40%). Case fatality rates ranged from 0.20% to 56.30% which in part reflects different inclusion criteria and context of the different studies, with some including all pneumonia patients, some only including severe pneumonia patients, and some only patients admitted to ICU.

Risk factors for mortality

Table 2 summarises the demographic, clinical, and laboratory factors investigated for association with mortality in included studies, restricted to factors reported in at least four studies. Additional factors studied in three or fewer studies are reported in Tables S2a-S2d in the Online Supplementary Document. Most risk factors of interest were reported in a small minority of studies, with only two demographic (age, sex), seven clinical (hypoxaemia, HIV infection, WHO severe pneumonia, severe malnutrition, comorbidities, tachypnoea), and two laboratory or aetiology (viral, bacterial) risk factors reported in more than 10% of included studies.

Table 2.  Associations of demographic, clinical, and laboratory factors with mortality, ranked by the proportion of studies finding an association (limited to factors reported in ≥4 studies)

WordPress Tables Plugin

CFR – case fatality rate, CRP – C-reactive protein, CXR – chest x-ray, HFAZ – height for age z-score, HIV – human immunodeficiency virus, HR – hazards ratio, OR – odds ratio, RR – risk ratio, RSV – respiratory syncytial virus, SpO2 – peripheral blood oxygen saturation, WCC – white cell count, WFAZ – weight for age z-score, WFHZ – weight for height z-score, WHO – World Health Organization

*Median OR/RR/HR and CFR reported where available, with ranges if reported in more than a single study.

†Estimates restricted to studies which defined hypoxaemia as SpO2<90%.

‡WHO severe pneumonia includes a composite of any of the following clinical signs: SpO2<90%, severe respiratory distress, altered conscious state, unable to feed/drink, convulsions, severe malnutrition, severe anaemia/pallor.

§Tachycardia typically defined as heart rate >160/minutes aged <12 months, >120/minutes aged 1-4 years, >100/minutes aged over 5 years.

‖Tachypnoea typically defined by age-specific respiratory rate: ≥60 aged <2 months, ≥50 aged 2-11 months, ≥40 aged 1-4 years, and ≥30 aged over 5 years.

¶Predominate negative association with mortality.

**Mixed positive and negative association.

Demographic and household factors

The demographic factors found to be most clearly associated with pneumonia mortality included younger age and inadequate immunization (Table 2). Data from 27 / 41 (66%) studies reporting on risks of death by age showed higher risk of death for younger children. Children aged under one year of age had a 2.5-fold higher risk of death (range from 1.4 to 29) than children aged one-four years and risk of death for infants under six months of age was particularly high. Fewer studies reported on the association between immunisation status and pneumonia mortality (n = 14), suggesting that under-immunised children have a 3-fold higher risk of death (range from 1.6 to 12.3) than fully immunised.

Female sex, inadequate breastfeeding, lower parental education level, lower socio-economic status, smoking exposure at home, and indoor pollution at home were all examined in at least four studies and found to be associated with mortality in up to half of those studies (Table 2). Data from eight studies reported that children from poorer families had a 2-fold higher risk of death (range from 2.2 to 2.9) than children from wealthier families, with similar increased risk for those with low parental education level compared to higher education (range from 1.4 to 4.4). Half the studies reporting smoking at home (n = 3 / 6) or indoor air pollution (n = 2 / 4) found an association with increased mortality. Suboptimal breastfeeding was found to be associated with mortality in infants with pneumonia in 4 / 7 (43%) of studies with fold higher risk of death (range from 1.7 to 4.4). Girls with pneumonia were found to have an approximate 30% increased risk of death compared to boys with a positive association between sex and mortality reported in one-quarter or 25% of studies (n = 9 / 36) that evaluated an association. This association between sex and mortality was found in diverse studies from Africa, Asia, and South America, with the elevated risk of death typically remaining after adjusting for other factors (e.g. age). Crowding at home was examined in four studies which did not find an association with pneumonia mortality.

Other demographic factors that were found to be associated with mortality in at least one study but reported in three or fewer studies included: low maternal age, past experience of child loss, living in a malaria endemic area, poor quality drinking water, late referral, lack of adequate sewage or latrine at home, and living in a rural area (Table S2a and Table S3a in the Online Supplementary Document). Antenatal care and birth spacing was only examined in one study and was associated with a lower risk of mortality.

Clinical factors

The clinical signs that were most clearly and strongly associated with mortality were decreased conscious state, hypoxaemia, cyanosis, malnutrition, severe pallor, and the presence of comorbid conditions (including HIV infection) (Table 2). Decreased conscious state was found to be associated with increased risk of death in all 12 studies that reported, associated with 7-fold higher risk of death (range from 3.1 to 324), with similar estimates from the fewer studies reporting on convulsions (Figure 2, panel A). Severe hypoxaemia (SpO2<90%) was associated with a 5.5-fold increased risk of death (range from 1.8 to 48.1) in 32 / 34 (94%) studies that reported it, while less severe hypoxaemia (e.g. SpO2 = 90%-93%) was also consistently associated with mortality (Figure 2, panel B, Table S3b in the Online Supplementary Document).

Figure 2.  Forest plot showing the unadjusted odds ratios (OR) for death among children with pneumonia from studies in low and middle-income countries (LMICs), comparing those with and without altered conscious state in Panel A or hypoxaemia in Panel B.

Severe acute malnutrition (based on weight for age / height) was found to increase risk of death 5-fold, while moderate wasting and stunting were also consistently associated with a 2-fold increase in risk of death (Figure 3, panel A and panel B, Table 2). The WHO “severe pneumonia” classification (cough or difficult breathing with hypoxaemia, SpO2<90%, or any danger sign – altered conscious state, convulsions, inability unable to feed/drink), was associated with a 4-fold increase in risk of death in 27 / 29 studies that reported it.

Figure 3.  Forest plot showing the unadjusted odds ratios (OR) for death among children with pneumonia from studies in low and middle-income countries (LMICs), comparing those with and without severe acute malnutrition in Panel A or moderate acute malnutrition in Panel B.

The presence of any chronic condition or comorbidity increased risk of death 5-fold (range from 1.9 to 18), with particular conditions such as congenital heart disease, HIV infection, neurodevelopmental conditions, anaemia, pre-term / low birth weight, being of particular concern. Conversely, the presence of asthma (or wheeze) was generally found to be associated with lower risk of death, with mixed findings about the impact of malaria co-infection. The presence of tachypnoea (fast breathing), diarrhoea, chest indrawing, and positive findings on chest auscultation were each found to be associated with a 2 to 3-fold increased risk of death. Fever and tachycardia were associated with increased risk of mortality in some studies, and decreased risk in others.

Other clinical factors that were found to be associated with mortality in at least one study but reported in three or fewer studies included: hypothermia t < 36.50, hypotension, signs of shock, meningitis, previous pneumonia admission, maternal disease in pregnancy, maternal tuberculosis, sepsis and stridor (Table S2a and Table S3b in the Online Supplementary Document).

Clinical investigations and aetiology

We generally found weak or inconsistent associations with mortality for aetiology other investigations (Table 2). While some studies found increased risk of death from bacterial causes of pneumonia and / or decreased risk of death from viral causes, most studies that explored the contribution of bacterial vs viral aetiologies found no association with risk of death. Of the individual bacterial aetiologies, the presence of PJP was found to be associated with 4-fold increase in risk of death (range from 1.9 to 5.3), from a small number of studies (n = 4). Of the viral aetiologies, there is some evidence for increased risk of death from parainfluenza and decreased risk of death from respiratory syncytial virus (RSV) and human metapneumovirus. Consolidation or pleural effusion on chest x-ray (CXR) were associated with a 4-fold increased risk of death compared to children with normal CXR. Data from a small number of studies suggested that high white cell count (leucocytosis) was not associated with mortality but low white cell count (leukopenia) was associated with increased risk of death. We found mixed findings regarding the association between mortality and elevation in C-reactive protein (CRP), a widely used inflammatory marker.

Other aetiological or clinical investigation factors that were found to be associated with mortality in at least one study but were examined in three or fewer studies included: pneumococcus, staphylococcus, influenza A, influenza B, H1N1 influenza, pneumothorax on CXR, electrolyte abnormality, hypoglycaemia, hyperglycaemia, thrombocytopaenia, low zinc, high lactate, acidaemia, low serum bicarbonate, and various markers of infection or inflammatory response (high procalcitonin, high ESR, high IL-1RA, high IL-6, high IL-8, high IL-17, high MIP-1a, high CK-MB fraction, high copeptin, high angiopoietin 2:angiopoietin 1 ratio, low angiopoietin 1, and low CCL22) (Table S2a, Table S3e and Table S3f in the Online Supplementary Document).

Risk factors for other types of severe treatment failure

Tables S2b-2d in the Online Supplementary Document summarise the associations between risk factors and hypoxaemia, intensive care unit (ICU) admission, and other forms of treatment failure for all factors in which the association with mortality was reviewed in at least four studies. Additional details are presented in Tables S3g-S3x in the Online Supplementary Document.

The numbers of papers reviewing these other endpoints was lower (which may reflect the search strategy’s focus on the primary endpoint of mortality). While there was general concordance in whether different factors were associated each of these endpoints, there were some notable differences. For example, while girls tended to have higher mortality than boys, sex was not associated with hypoxaemia or treatment failure, and girls were less likely to be admitted to ICU than boys. Similarly, while viral aetiology (e.g. influenza, RSV) was associated with hypoxaemia, it was not associated with ICU admission or other treatment failure. Among the clinical risk factors, hypoxaemia, tachypnoea, chest indrawing, and the presence of comorbidities were all consistently associated with hypoxaemia, ICU admission, and other treatment failure. Malnutrition was not clearly associated with hypoxaemia but was associated with ICU admission and other treatment failure, perhaps indicating that children with malnutrition present with similar pneumonia severity but have worse disease progression and recovery.


Our systematic review identified important risk factors for treatment failure or mortality in children with pneumonia. We found many factors that may be associated with mortality, including demographic, maternal, socioeconomic, environmental, laboratory, and radiological factors. The most consistently demonstrated risk factors for child pneumonia death are almost all clinical – young age, inadequate immunization, hypoxaemia, altered conscious state, malnutrition, anaemia, and comorbid conditions. However, clinical risk factors were also the most commonly reported and it is possible that other less-studied risk factors could emerge as important in future studies.

Our findings share similarities to Sonego et al.’s (2015) review of risk factors for child pneumonia mortality [154]. While Sonego et al. included studies as far back as 1988 (n = 61/77 were published before 2010), we focussed on recent studies (published since 2010), identifying many papers not included in the Sonego review and excluding some that the Sonego review included (mostly because they restricted to a narrow population, such as RSV or HIV-infected). Like our review, the Sonego review identified young age, comorbid chronic conditions, malnutrition, unimmunised status, and Pneumocystis jirovecii as major risk factors for child pneumonia death. Two of the major clinical risk factors we identified (hypoxaemia and altered conscious state) were not examined in the Sonego review, with a subsequent review focussed on hypoxaemia clearly confirming it as a major risk factor for death [155]. Compared to the Sonego review, we found less consistent association between socio-economic status, smoking or indoor air pollution and child pneumonia mortality. Both our review and Sonego’s review found evidence of girls with pneumonia having poorer outcomes than boys, possibly related to differential care-seeking and treatment practices, although results from individual studies were mixed. The Sonego review did not explore laboratory and radiological predictors of mortality or individual clinical signs.

Implications for policy and practice

Many child deaths are predictable based on a few specific risk factors and there are increasing calls to improve risk stratification of existing child health guidelines [1]. Our review highlights risk factors for mortality among children with pneumonia and presents opportunities to improve current guidance and strategies for pneumonia control.

Current pneumonia control strategies identify particular priorities for protection (breastfeeding, supplemental feeding), prevention (immunization, handwashing, HIV-prevention, reduced household air pollution) and treatment (care seeking, case management, antibiotics, oxygen) [156]. Our review supports an emphasis on prevention and treatment of malnutrition and the critical role of immunization and HIV-prevention. While factors such as indoor air pollution and breastfeeding did not emerge as major risk factors for death among children with pneumonia, they remain important in reducing pneumonia incidence in the first place. In addition, we urge added attention to the prevention and treatment of anaemia, and the identification and preventive management of other chronic conditions and comorbidities such as congenital and neurodevelopmental conditions.

In terms of diagnosis and treatment, our review highlights clear opportunities to improve the identification of children with pneumonia who are at high risk of death. First, while malnutrition and hypoxaemia are included in the WHO severe pneumonia classification, current clinical guidelines generally focus on severe forms – severe acute malnutrition (SAM) and SpO2<90%. Our review shows than even moderate malnutrition and hypoxaemia (SpO2<94%) are associated with increased mortality. Furthermore, conscious state, nutritional status, and blood oxygen levels are poorly assessed in routine clinical care. Routine pulse oximetry, anthropometric measurement (e.g. MUAC), and assessment of conscious state (e.g. AVPU) is critical to identify high-risk patients.

Second, chronic underlying health conditions are not routinely assessed in current treatment algorithms and guidelines, which have traditionally focused on acute infectious killers. Chronic conditions are common and important to be addressed in their own right [157], but should also be considered a major risk factor for children presenting with acute illness. So, while continued emphasis on particular conditions such as malnutrition, anaemia, and HIV infection is warranted, guidelines should also encourage routine identification of any chronic illness or comorbidity and recognise that this puts children at higher risk of poor outcome.

Third, anaemia is a major risk factor for death but is difficult to detect clinically with current WHO guidelines relying on the clinical finding of “severe pallor”. Technology exists for point-of-care haemoglobin measurement, including non-invasive devices integrated with pulse oximetry [158]. Increased access to low-cost point-of-care haemoglobin tools may be particularly useful in malaria-endemic settings where anaemia is particularly common and deadly.

Future research may further define the role of additional laboratory investigations, such as lactate or procalcitonin, in defined populations (e.g. HDU/ICU).

Improved risk assessment and stratification has potential benefits for patients, health care workers, and broader health systems and communities. Severely ill patients can benefit from more prompt and timely diagnosis and access to appropriate treatment. Healthcare workers can more easily decide where to care for patients (e.g. inpatient, outpatient, HDU/ICU), how frequently to monitor and review patients, and when to escalate therapy. Health managers can make better decisions about which populations should be cared for in what level of facility and allocate resources accordingly. The wider community can have greater confidence that their loved ones will be cared for according to need.


We used broad search criteria to capture studies reporting a wide range of potential risk factors for child pneumonia death and included studies from diverse geographical contexts. However, the quality of included studies was generally low and many risk factors were only examined in a small number of studies and limited geographical contexts. For reporting integrity we have included all results in supplemental material but focused our results on risk factors that have been consistently reported in multiple studies. It is possible that risk factors that have not been well explored in the literature to date will emerge with more data. Most included studies were hospital based, with over-representation of large urban hospitals. A high proportion of pneumonia deaths in low- and middle-income countries happen outside of hospital and examining pneumonia at the community or primary care level may reveal different risk factors or risk estimates [1,5]. Furthermore, by only comparing risk factors between patients who have already been admitted to hospital we risk over- or under- emphasising factors that are commonly used to decide about admission (e.g. chest indrawing). Most included studies used the WHO clinical case definition for pneumonia, with few including radiographic evidence or distinguishing pneumonia from conditions such as bronchiolitis or asthma. We know that clinical pneumonia overlaps in features with other common conditions, such as malaria, and this can result in both over-diagnosis and under-diagnosis [159]. However, this represents the case mix reality faced in many health facilities in low- and middle-income countries where clinical features must be relied upon. Our study reviewed the association with mortality among patients with pneumonia, and therefore factors which increase the risk of acquiring pneumonia in the first place (and therefore lead to an increased lifetime risk of dying from pneumonia) may not be highlighted.


Many studies of children with pneumonia in LMICs have investigated the association between clinical factors and mortality. A smaller number of studies have investigated sociodemographic, epidemiological and laboratory factors and their relationship to mortality.

Hypoxaemia (low blood oxygen level), decreased conscious state, severe acute malnutrition, and the presence of an underlying chronic condition were the risk factors most strongly and consistently associated with increased mortality in children with pneumonia. Additional important clinical factors that were associated with mortality in the majority of studies included particular clinical signs (cyanosis, pallor, tachypnoea, chest indrawing, convulsions, diarrhoea), chronic comorbidities (anaemia, HIV infection, congenital heart disease, heart failure), as well as other non-severe forms of malnutrition. Important demographic factors associated with mortality in the majority of studies included age <12 months and inadequate immunisation. Important laboratory and investigation findings associated with mortality in the majority of studies included: confirmed PJP, consolidation on chest x-ray, pleural effusion on chest x-ray, and leukopenia. Several other demographic, clinical and laboratory findings were associated with mortality less consistently or in a small numbers of studies.

Routine assessment of blood oxygen levels, nutritional status, conscious state and comorbidities are critical for effective risk assessment and clinical decision making. The strong association of HIV, anaemia, comorbidities, and malnutrition with mortality highlights the importance of good quality primary and preventative care, and early care seeking.

Additional material

Online Supplementary Document


Thanks to Poh Chua, research librarian, for substantial technical support in setting up and running the database searches, and Helen Thomson and Haset Samuel for administrative support.

Data availability: All relevant data is reported in the manuscript or supplemental material.

[1] Funding: This work was funded by a grant from the World Health Organization (WHO) to the Murdoch Children’s Research Institute (MCRI). Employees of WHO contributed to the design and oversight of the reviews. Any views or opinions presented are solely those of the author and do not necessarily represent those of the World Health Organization, unless otherwise specifically stated.

[2] Authorship contributions: TD, HG and members of the ARI Review group conceived the study and initiated the study design. CW and MB led the conduct of searches and data extraction. Data analysis was conducted by CW, MB, and HG. The manuscript was drafted by CW and MB, with input from TD and HG. All authors contributed to revisions and approved the final manuscript.

[3] Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding author) and disclose no relevant interests.


[1] . Childhood mortality during and after acute illness in Africa and south Asia: a prospective cohort study. Lancet Glob Health. 2022;10:e673-84. DOI: 10.1016/S2214-109X(22)00118-8. [PMID:35427524]

[2] World Health Organization. Revised WHO classification and treatment of childhood pneumonia at health facilities: Evidence summaries. Switzerland: WHO; 2014. Available at: Accessed:13 February 2023.

[3] WHO. Pocket Book of Hospital care for children: guidelines for the management of common childhood illnesses. 2nd ed. Geneva: World Health Organization; 2013.

[4] WHO. Integrated Management of Childhood Illness – Chart Booklet. Geneva: World Health Organization (WHO); 2014.

[5] DA McAllister, L Liu, T Shi, Y Chu, C Reed, and J Burrows. Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Glob Health. 2019;7:e47-57. DOI: 10.1016/S2214-109X(18)30408-X. [PMID:30497986]

[6] . Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet. 2019;394:757-779. DOI: 10.1016/S0140-6736(19)30721-4. [PMID:31257127]

[7] BH Thomas, D Ciliska, M Dobbins, and S Micucci. A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs. 2004;1:176-84. DOI: 10.1111/j.1524-475X.2004.04006.x. [PMID:17163895]

[8] S Armijo-Olivo, CR Stiles, NA Hagen, PD Biondo, and GG Cummings. Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research. J Eval Clin Pract. 2012;18:12-8. DOI: 10.1111/j.1365-2753.2010.01516.x. [PMID:20698919]

[9] MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, and CD Mulrow. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71 DOI: 10.1136/bmj.n71. [PMID:33782057]

[10] M Campbell, JE McKenzie, A Sowden, SV Katikireddi, SE Brennan, and S Ellis. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890 DOI: 10.1136/bmj.l6890. [PMID:31948937]

[11] MB Abdulkadir, RM Ibraheem, AA Gobir, and WB Johnson. Hypoxaemia as a measure of disease severity in young hospitalised Nigerian children with pneumonia: A cross-sectional study. SAJCH. 2015;9:53-6.

[12] J Acuna, F Galeano, C Aguiar, V Delgado, C Martinez, and D Lovera. Risk factors for mortality in children with severe community-acquired pneumonia admitted to an pediatric intensive care unit. Pediatr Crit Care Med. 2018;19:6Suppl 1101-2. DOI: 10.1097/01.pcc.0000537632.62024.c3

[13] OA Adewuyi, S Mda, and T Kyaw. Incidence of cytomegalovirus(CMV) pneumonia among children presenting with severe lower respiratory tract infection at dr george mukhari hospital. Arch Dis Child. 2012;97:A261 DOI: 10.1136/archdischild-2012-302724.0912

[14] A Agweyu, D Gathara, J Oliwa, N Muinga, T Edwards, and E Allen. Oral amoxicillin versus benzyl penicillin for severe pneumonia among kenyan children: a pragmatic randomized controlled noninferiority trial. Clin Infect Dis. 2015;60:1216-24. DOI: 10.1093/cid/ciu1166. [PMID:25550349]

[15] A Agweyu, RJ Lilford, and M English. Clinical Information Network Author G. Appropriateness of clinical severity classification of new WHO childhood pneumonia guidance: a multi-hospital, retrospective, cohort study. Lancet Glob Health. 2018;6:e74-83. DOI: 10.1016/S2214-109X(17)30448-5. [PMID:29241618]

[16] A Agweyu, J Oliwa, D Gathara, N Muinga, E Allen, and RJ Lilford. Comparable outcomes among trial and nontrial participants in a clinical trial of antibiotics for childhood pneumonia: a retrospective cohort study. J Clin Epidemiol. 2018;94:1-7. DOI: 10.1016/j.jclinepi.2017.10.016. [PMID:29097339]

[17] F Ahmed, ZA Memon, A Mehnaz, BA Khokhar, S Alvi, and N Ahmed. A study on the effects of malnutrition on pediatric pneumonia patients. Pak Pediatr J. 2016;40:17-21.

[18] MLCB Ahmed, A Weddih, M Benhafid, MA Bollahi, M Sidatt, and K Makhalla. Hospitalizations and Deaths Associated with Diarrhea and Respiratory Diseases among Children Aged 0-5 Years in a Referral Hospital of Mauritania. Trop Med Infect Dis. 2018;3:103 DOI: 10.3390/tropicalmed3030103. [PMID:30274499]

[19] MA Al Amad, AA Al Mahaqri, AA Al Serouri, and YS Khader. Severe Acute Respiratory Infections With Influenza and Noninfluenza Respiratory Viruses: Yemen, 2011-2016. Inquiry. 2019;56:46958019850731. [PMID:31137990]

[20] SA Ali, F Aziz, N Akhtar, S Qureshi, K Edwards, and A Zaidi. Pandemic influenza A(H1N1)pdm09: an unrecognized cause of mortality in children in Pakistan. Scand J Infect Dis. 2013;45:791-5. DOI: 10.3109/00365548.2013.803292. [PMID:23826795]

[21] Alohan AO, Bakare AA, Ayede AI, Falade AG. Prevalence of hypoxemia amongst children with pneumonia in secondary health facilities in nigeria. American Journal of Respiratory and Critical Care Medicine Conference. 2019;199.

[22] S Araya, D Lovera, C Zarate, S Apodaca, J Acuna, and G Sanabria. Application of a Prognostic Scale to Estimate the Mortality of Children Hospitalized with Community-acquired Pneumonia. Pediatr Infect Dis J. 2016;35:369-73. DOI: 10.1097/INF.0000000000001018. [PMID:26629871]

[23] ZTH Atwa. Usefulness of gender and abnormal blood count for predicting pneumonia outcome in children. Egypt J Chest Dis Tuberc. 2015;64:169-74. DOI: 10.1016/j.ejcdt.2014.11.022

[24] S Awad, Y Khader, M Mansi, D Yusef, S Alawadin, and W Qudah. Viral Surveillance of Children with Acute Respiratory Infection in Two Main Hospitals in Northern Jordan, Irbid, during Winter of 2016. J Pediatr Infect Dis. 2020;15:1-10. DOI: 10.1055/s-0039-1692972. [PMID:32300275]

[25] S Awasthi, KK Yadav, M Pandey, AA Mahdi, and N Awasthi. Interleukin 1 receptor antagonist (IL1RA) gene polymorphism and levels associated with adverse outcome in severe community-acquired pneumonia in children: A hospital-based study in India. Pediatr Pulmonol. 2018;53:1276-83. DOI: 10.1002/ppul.24090. [PMID:29943912]

[26] P Ayieko, EA Okiro, T Edwards, R Nyamai, and M English. Variations in mortality in children admitted with pneumonia to Kenyan hospitals. PLoS One. 2012;7:e47622. DOI: 10.1371/journal.pone.0047622. [PMID:23139752]

[27] SF Azab, MA Abdalhady, HF Elsaadany, MA Elkomi, EM Elhindawy, and DT Sarhan. Interleukin-10 -1082 G/A gene polymorphisms in Egyptian children with CAP: A case-control study. Medicine (Baltimore). 2016;95:e4013. DOI: 10.1097/MD.0000000000004013. [PMID:27368016]

[28] SF Azab, LM Sherief, SH Saleh, WF Elsaeed, MA Elshafie, and SM Abdelsalam. Impact of the socioeconomic status on the severity and outcome of community-acquired pneumonia among Egyptian children: a cohort study. Infect Dis Poverty. 2014;3:14 DOI: 10.1186/2049-9957-3-14. [PMID:24834348]

[29] B Barger-Kamate, MD Knoll, EW Kagucia, C Prosperi, HC Baggett, and WA Brooks. Pertussis-associated pneumonia in infants and children from low-and middle-income countries participating in the perch study. Clin Infect Dis. 2016;63:S187-96. DOI: 10.1093/cid/ciw546. [PMID:27838672]

[30] S Basnet, A Sharma, M Mathisen, PS Shrestha, RK Ghimire, and DM Shrestha. Predictors of duration and treatment failure of severe pneumonia in hospitalized young Nepalese children. PLoS One. 2015;10:e0122052. DOI: 10.1371/journal.pone.0122052. [PMID:25798907]

[31] F Bekele, M Sinaga, JA Quadri, A Kumar, A Shariff, and T Malik. Factors associated with outcomes of severe pneumonia in children aged 2 months to 59 months at jimma university specialized hospital, southwest Ethiopia. Curr Pediatr Res. 2017;21:447-54.

[32] T Bénet, VS Picot, S Awasthi, N Pandey, A Bavdekar, and A Kawade. Severity of Pneumonia in Under 5-Year-Old Children from Developing Countries: A Multicenter, Prospective, Observational Study. Am J Trop Med Hyg. 2017;97:68-76. DOI: 10.4269/ajtmh.16-0733. [PMID:28719310]

[33] JA Berkley, P Munywoki, M Ngama, S Kazungu, J Abwao, and A Bett. Viral etiology of severe pneumonia among Kenyan infants and children. JAMA. 2010;303:2051-7. DOI: 10.1001/jama.2010.675. [PMID:20501927]

[34] PG Bezerra, MC Britto, JB Correia, C Duarte Mdo, AM Fonceca, and K Rose. Viral and atypical bacterial detection in acute respiratory infection in children under five years. PLoS One. 2011;6:e18928. DOI: 10.1371/journal.pone.0018928. [PMID:21533115]

[35] CB Bills, JA Newberry, GVR Rao, LW Matheson, S Rao, and SV Mahadevan. Acute respiratory illness among a prospective cohort of pediatric patients using emergency medical services in India: Demographic and prehospital clinical predictors of mortality. PLoS One. 2020;15:e0230911. DOI: 10.1371/journal.pone.0230911. [PMID:32240227]

[36] AR Bjorklund, B Odongkara Mpora, ME Steiner, G Fischer, CS Davey, and TM Slusher. Use of a modified bubble continuous positive airway pressure (bCPAP) device for children in respiratory distress in low- and middle-income countries: a safety study. Paediatr Int Child Health. 2019;39:160-7. DOI: 10.1080/20469047.2018.1474698. [PMID:29912645]

[37] CM Bokade, AD Madhura, AS Bagul, and SB Thakre. Predictors of mortality in children due to severe and very severe pneumonia. Niger Med J. 2015;56:287-91. DOI: 10.4103/0300-1652.165038. [PMID:26759516]

[38] R Boukari, C Kaddache, S Touri, R Mezeghrani, K Mammeri, and N Benali Khoudja. Acute-acquired pneumonia in children in hospital setting in Algeria. Paediatr Respir Rev. 2011;12:S72-3. DOI: 10.1016/S1526-0542(11)70077-X

[39] S Caggiano, N Ullmann, E De Vitis, M Trivelli, C Mariani, and M Podagrosi. Factors That Negatively Affect the Prognosis of Pediatric Community-Acquired Pneumonia in District Hospital in Tanzania. Int J Mol Sci. 2017;18:623 DOI: 10.3390/ijms18030623. [PMID:28335406]

[40] J Champatiray, J Satapathy, B Kashyap, and D Mondal. Clinico-Aetiological Study of Severe and Very Severe Pneumonia in Two Months to Five Years Children in a Tertiary Health Care Centre in Odisha, India. J Clin Diagn Res. 2017;11:SC06-10. DOI: 10.7860/JCDR/2017/26027.10595. [PMID:29207796]

[41] MJ Chisti, T Ahmed, ASG Faruque, and M Abdus Salam. Clinical and laboratory features of radiologic pneumonia in severely malnourished infants attending an urban diarrhea treatment center in Bangladesh. Pediatr Infect Dis J. 2010;29:174-7. DOI: 10.1097/INF.0b013e3181b9a4d5. [PMID:19927041]

[42] F Chowdhury, A Shahid, PK Ghosh, M Rahman, MZ Hassan, and Z Akhtar. Viral etiology of pneumonia among severely malnourished under-five children in an urban hospital, Bangladesh. PLoS One. 2020;15:e0228329. DOI: 10.1371/journal.pone.0228329. [PMID:32017782]

[43] C Cohen, S Walaza, J Moyes, M Groome, S Tempia, and M Pretorius. Epidemiology of viral-associated acute lower respiratory tract infection among children <5 years of age in a high HIV prevalence setting, South Africa, 2009-2012. Pediatr Infect Dis J. 2015;34:66-72. DOI: 10.1097/INF.0000000000000478. [PMID:25093972]

[44] K Cotes, J Moreno-Montoya, A Porras-Ramirez, A Rico-Mendoza, and F de la Hoz-Restrepo. Clinical characteristics of patients hospitalized with severe respiratory illness during influenza seasons in the cities of Bogota and Manizales, Colombia 2000-2006. Rev Salud Publica (Bogota). 2012;14:129-42. DOI: 10.1590/S0124-00642012000100011. [PMID:23250321]

[45] S Daga, C Valvi, and M Ayarekar. Comprehensive management reduces deaths associated with chest indrawing in children. Pediatr Crit Care Med. 2014;15:4Suppl140 DOI: 10.1097/01.pcc.0000449345.27989.5a

[46] BPP Dembele, T Kamigaki, C Dapat, R Tamaki, M Saito, and M Saito. Aetiology and risks factors associated with the fatal outcomes of childhood pneumonia among hospitalised children in the Philippines from 2008 to 2016: a case series study. BMJ Open. 2019;9:e026895. DOI: 10.1136/bmjopen-2018-026895. [PMID:30928958]

[47] N Díez-Padrisa, Q Bassat, S Machevo, L Quinto, L Morais, and T Nhampossa. Procalcitonin and C-reactive protein for invasive bacterial pneumonia diagnosis among children in Mozambique, a malaria-endemic area. PLoS One. 2010;5:e13226. DOI: 10.1371/journal.pone.0013226. [PMID:20976241]

[48] C Divecha, MS Tullu, and S Chaudhary. Burden of respiratory illnesses in pediatric intensive care unit and predictors of mortality: Experience from a low resource country. Pediatr Pulmonol. 2019;54:1234-41. DOI: 10.1002/ppul.24351. [PMID:31087783]

[49] AH Do, HR van Doorn, MN Nghiem, JE Bryant, TH Hoang, and QH Do. Viral etiologies of acute respiratory infections among hospitalized Vietnamese children in Ho Chi Minh City, 2004-2008. PLoS One. 2011;6:e18176. DOI: 10.1371/journal.pone.0018176. [PMID:21455313]

[50] GS Durigon, DB Oliveira, MC Felicio, C Finelli, MF Pereira, and JG Storni. Poor outcome of acute respiratory infection in young children with underlying health condition in Brazil. Int J Infect Dis. 2015;34:3-7. DOI: 10.1016/j.ijid.2015.03.003. [PMID:25747778]

[51] GO Emukule, M McMorrow, C Ulloa, S Khagayi, HN Njuguna, and D Burton. Predicting mortality among hospitalized children with respiratory illness in Western Kenya, 2009-2012. PLoS One. 2014;9:e92968. DOI: 10.1371/journal.pone.0092968. [PMID:24667695]

[52] PM Enarson, RP Gie, CC Mwansambo, AE Chalira, NN Lufesi, and ER Maganga. Potentially Modifiable Factors Associated with Death of Infants and Children with Severe Pneumonia Routinely Managed in District Hospitals in Malawi. PLoS One. 2015;10:e0133365. DOI: 10.1371/journal.pone.0133365. [PMID:26237222]

[53] PM Enarson, RP Gie, CC Mwansambo, ER Maganga, CJ Lombard, and DA Enarson. Reducing deaths from severe pneumonia in children in Malawi by improving delivery of pneumonia case management. PLoS One. 2014;9:e102955. DOI: 10.1371/journal.pone.0102955. [PMID:25050894]

[54] O Evelyn, FS Jaime, M David, A Lorena, A Jenifer, and G Oscar. Prevalence, clinical outcomes and rainfall association of acute respiratory infection by human metapneumovirus in children in Bogota, Colombia. BMC Pediatr. 2019;19:345 DOI: 10.1186/s12887-019-1734-x. [PMID:31601181]

[55] C Ezeonu, C Uneke, J Ojukwu, O Anyanwu, C Okike, and O Ezeanosike. The pattern of pediatric respiratory illnesses admitted in ebonyi state university teaching hospital South-East Nigeria. Ann Med Health Sci Res. 2015;5:65-70. DOI: 10.4103/2141-9248.149792. [PMID:25745580]

[56] Fagbohun AO, Yaria JO, Oyewole OB, Ayede AI, Falade AG. Application of a prognostic scale to estimate the outcome of hospitalized children with pneumonia. American Journal of Respiratory and Critical Care Medicine Conference: American Thoracic Society International Conference, ATS. 2020;201.

[57] N Fancourt, M Deloria Knoll, HC Baggett, WA Brooks, DR Feikin, and LL Hammitt. Chest Radiograph Findings in Childhood Pneumonia Cases From the Multisite PERCH Study. Clin Infect Dis. 2017;64:S262-70. DOI: 10.1093/cid/cix089. [PMID:28575361]

[58] DR Feikin, W Fu, DE Park, Q Shi, MM Higdon, and HC Baggett. Is higher viral load in the upper respiratory tract associated with severe pneumonia? Findings from the PERCH study. Clin Infect Dis. 2017;64:S337-46. DOI: 10.1093/cid/cix148. [PMID:28575373]

[59] FM Ferolla, DR Hijano, PL Acosta, A Rodriguez, K Duenas, and A Sancilio. Macronutrients during pregnancy and life-threatening respiratory syncytial virus infections in children. Am J Respir Crit Care Med. 2013;187:983-90. DOI: 10.1164/rccm.201301-0016OC. [PMID:23449690]

[60] S Ferreira, CC Sant’anna, F March Mde, MA Santos, and AJ Cunha. Lethality by pneumonia and factors associated to death. J Pediatr (Rio J). 2014;90:92-7. DOI: 10.1016/j.jped.2013.05.008. [PMID:24161238]

[61] G Fischer Langley, J McCracken, W Arvelo, A Estevez, G Villarruel, and M Prill. The epidemiology and clinical characteristics of young children hospitalized with respiratory syncytial virus infections in Guatemala (2007-2010). Pediatr Infect Dis J. 2013;32:629-35. DOI: 10.1097/INF.0b013e318289e3bc. [PMID:23380666]

[62] KE Gallagher, MD Knoll, C Prosperi, HC Baggett, WA Brooks, and DR Feikin. The Predictive Performance of a Pneumonia Severity Score in Human Immunodeficiency Virus-negative Children Presenting to Hospital in 7 Low- and Middle-income Countries. Clin Infect Dis. 2020;70:1050-7. [PMID:31111870]

[63] V Gowraiah, S Awasthi, R Kapoor, D Sahana, P Venkatesh, and B Gangadhar. Can we distinguish pneumonia from wheezy diseases in tachypnoeic children under low-resource conditions? A prospective observational study in four Indian hospitals. Arch Dis Child. 2014;99:899-906. DOI: 10.1136/archdischild-2013-305740. [PMID:24925892]

[64] H Graham, AA Bakare, AI Ayede, OB Oyewole, A Gray, and D Peel. Hypoxaemia in hospitalised children and neonates: A prospective cohort study in Nigerian secondary-level hospitals. EClinicalMedicine. 2019;16:51-63. DOI: 10.1016/j.eclinm.2019.10.009. [PMID:31832620]

[65] SM Graham, L Mankhambo, A Phiri, S Kaunda, T Chikaonda, and M Mukaka. Impact of human immunodeficiency virus infection on the etiology and outcome of severe pneumonia in Malawian children. Pediatr Infect Dis J. 2011;30:33-8. DOI: 10.1097/INF.0b013e3181fcabe4. [PMID:21173674]

[66] R Hasan, J Rhodes, S Thamthitiwat, SJ Olsen, P Prapasiri, and S Naorat. Incidence and etiology of acute lower respiratory tract infections in hospitalized children younger than 5 years in rural Thailand. Pediatr Infect Dis J. 2014;33:e45-52. DOI: 10.1097/INF.0000000000000062. [PMID:24030346]

[67] A Hatem, S Mohamed, UE Abu Elhassan, EAM Ismael, MS Rizk, and A El-Kholy. Clinical characteristics and outcomes of patients with severe acute respiratory infections (SARI): results from the Egyptian surveillance study 2010-2014. Multidiscip Respir Med. 2019;14:11 DOI: 10.1186/s40248-019-0174-7. [PMID:30976418]

[68] S Hooli, T Colbourn, N Lufesi, A Costello, B Nambiar, and S Thammasitboon. Predicting Hospitalised Paediatric Pneumonia Mortality Risk: An External Validation of RISC and mRISC, and Local Tool Development (RISC-Malawi) from Malawi. PLoS One. 2016;11:e0168126. DOI: 10.1371/journal.pone.0168126. [PMID:28030608]

[69] HK Hutton, HJ Zar, and AC Argent. Clinical Features and Outcome of Children with Severe Lower Respiratory Tract Infection Admitted to a Pediatric Intensive Care Unit in South Africa. J Trop Pediatr. 2019;65:46-54. DOI: 10.1093/tropej/fmy010. [PMID:29534241]

[70] RM Ibraheem, JA Aderemi, MB Abdulkadir, and WBR Johnson. Burden and spectrum of paediatric respiratory diseases at a referral hospital in North-Central Nigeria – A five year review. Afr J Emerg Med. 2020;10:3-7. DOI: 10.1016/j.afjem.2019.09.001. [PMID:32161704]

[71] SA Indriyani and PK Dewi. Outcomes of children hospitalized with pneumonia in West Nusa Tenggara Province general hospital Indonesia. Pediatr Pulmonol. 2018;53:Suppl 1S117

[72] SA Indriyani, DA Wulandari, and CB Kartasasmita. Biomarkers as outcome predictor of children hospitalized with severe community-acquired pneumonia in west nusa tenggara province general hospital. Pediatr Pulmonol. 2019;54:Suppl 1S92

[73] PY Iroh Tam, MO Wiens, J Kabakyenga, J Kiwanuka, E Kumbakumba, and PP Moschovis. Pneumonia in HIV-exposed and Infected Children and Association With Malnutrition. Pediatr Infect Dis J. 2018;37:1011-3. DOI: 10.1097/INF.0000000000001971. [PMID:29505479]

[74] A Jain, N Awasthi, and S Awasthi. Low platelet counts predict mortality in severe community acquired pneumonia in children under 5 years of age: A hospital based observational study. Clin Epidemiol Glob Health. 2018;6:188-91. DOI: 10.1016/j.cegh.2018.02.007

[75] SK Jakhar, M Pandey, D Shah, VG Ramachandran, R Saha, and N Gupta. Etiology and Risk Factors Determining Poor Outcome of Severe Pneumonia in Under-Five Children. Indian J Pediatr. 2018;85:20-4. DOI: 10.1007/s12098-017-2514-y. [PMID:29027126]

[76] I Jroundi, C Mahraoui, R Benmessaoud, C Moraleda, H Tligui, and M Seffar. The epidemiology and aetiology of infections in children admitted with clinical severe pneumonia to a university hospital in Rabat, Morocco. J Trop Pediatr. 2014;60:270-8. DOI: 10.1093/tropej/fmu010. [PMID:24570343]

[77] I Jroundi, C Mahraoui, R Benmessaoud, C Moraleda, H Tligui, and M Seffar. Risk factors for a poor outcome among children admitted with clinically severe pneumonia to a university hospital in Rabat, Morocco. Int J Infect Dis. 2014;28:164-70. DOI: 10.1016/j.ijid.2014.07.027. [PMID:25305555]

[78] S Jullien, D Pradhan, T Tshering, R Sharma, K Dema, and S Garcia-Garcia. Pneumonia in children admitted to the national referral hospital in Bhutan: A prospective cohort study. Int J Infect Dis. 2020;95:74-83. DOI: 10.1016/j.ijid.2020.04.017. [PMID:32283281]

[79] MS Kelly, M Smieja, K Luinstra, KE Wirth, DM Goldfarb, and AP Steenhoff. Association of respiratory viruses with outcomes of severe childhood pneumonia in Botswana. PLoS One. 2015;10:e0126593. DOI: 10.1371/journal.pone.0126593. [PMID:25973924]

[80] MS Kelly, KE Wirth, AP Steenhoff, CK Cunningham, T Arscott-Mills, and SC Boiditswe. Treatment Failures and Excess Mortality Among HIV-Exposed, Uninfected Children With Pneumonia. J Pediatric Infect Dis Soc. 2015;4:e117-26. DOI: 10.1093/jpids/piu092. [PMID:26582879]

[81] MS Kelly, J Zheng, S Boiditswe, AP Steenhoff, KA Feemster, and T Arscott-Mills. Investigating Mediators of the Poor Pneumonia Outcomes of Human Immunodeficiency Virus-Exposed but Uninfected Children. J Pediatric Infect Dis Soc. 2019;8:13-20. DOI: 10.1093/jpids/pix092. [PMID:29165579]

[82] N Khuri-Bulos, L Lawrence, B Piya, L Wang, C Fonnesbeck, and S Faouri. Factors associated with severity of respiratory viral illnesses in hospitalized Jordanian children. J Infect Public Health. 2020;13:460 DOI: 10.1016/j.jiph.2020.02.010

[83] Kim PNT, Tran H, Tran T, Fitzgerald D, Graham S, Marais B. Reducing unnecessary antibiotic use and hospitalization in children with pneumonia. European Respiratory Journal Conference: 29th International Congress of the European Respiratory Society, ERS Spain. 2019;54.

[84] C King, ED McCollum, L Mankhambo, T Colbourn, J Beard, and DC Hay Burgess. Can We Predict Oral Antibiotic Treatment Failure in Children with Fast-Breathing Pneumonia Managed at the Community Level? A Prospective Cohort Study in Malawi. PLoS One. 2015;10:e0136839. DOI: 10.1371/journal.pone.0136839. [PMID:26313752]

[85] MF Korkmaz, A Güzel, M Açıkgöz, A Okuyucu, and H Alaçam. Reliability of Pro-adrenomedullin and Interleukin 1β in Predicting Severity of Community-Acquired Pneumonia in Pediatric Patients. Ann Clin Lab Sci. 2018;48:81-9. [PMID:29531001]

[86] BC KuMR ZonfrilloU PeriyanayagamM BisanzoB RiceS MalingThe Association of Malnutrition and Disease Conditions in Mortality of Pediatric Patients Presenting to a Rural Emergency Department in Uganda. Pediatr Emerg Care. 2021;37:e1515-e1520. DOI: 10.1097/PEC.0000000000002102

[87] BP Kuti, SA Adegoke, BE Ebruke, S Howie, OA Oyelami, and MOC Ota. Risk factors for mortality in childhood pneumonia in a rural West African region. J Pediatr Infect Dis. 2013;8:131-8.

[88] M Laman, P Ripa, J Vince, and N Tefuarani. Head nodding predicts mortality in young hypoxaemic Papua New Guinean children with acute lower respiratory tract infection. J Trop Pediatr. 2013;59:75-6. DOI: 10.1093/tropej/fms048. [PMID:23070739]

[89] M LanaspaC O’Callaghan-GordoS MachevoL MadridT NhampossaS AcacioHigh prevalence of Pneumocystis jirovecii pneumonia among Mozambican children <5 years of age admitted to hospital with clinical severe pneumonia. Clin Microbiol Infect. 2015;21:1018.e9-1018.e15. DOI: 10.1016/j.cmi.2015.07.011

[90] M Lazzerini, N Seward, N Lufesi, R Banda, S Sinyeka, and G Masache. Mortality and its risk factors in Malawian children admitted to hospital with clinical pneumonia, 2001-12: a retrospective observational study. Lancet Glob Health. 2016;4:e57-68. DOI: 10.1016/S2214-109X(15)00215-6. [PMID:26718810]

[91] DM le Roux, L Myer, MP Nicol, and HJ Zar. Incidence and severity of childhood pneumonia in the first year of life in a South African birth cohort: the Drakenstein Child Health Study. Lancet Glob Health. 2015;3:e95-103. DOI: 10.1016/S2214-109X(14)70360-2. [PMID:25617203]

[92] EJ LimaMJ MelloMF AlbuquerqueMI LopesGH SerraMA Abreu-LimaClinical and epidemiological characteristics of severe community-acquired pneumonia in children after introduction of the 10-valent pneumococcal vaccine. Pediatric Health Med Ther. 2015;6:131-138. DOI: 10.2147/PHMT.S88132

[93] DA Lozano-Espinosa, VM Huertas-Quinones, and CE Rodriguez. Congenital heart disease with hemodynamic repercussion and pulmonary hypertension as predictors of severity in children under five years hospitalized for acute respiratory infection. Cardiol Young. 2019;29:Suppl 1S183

[94] Lufesi NN, Lazzerini M, Seward N, Masache G, Makwenda C, Nambiar B, et al. Public health burden and mortality of hospitalized clinical pneumonia in Malawian children, 2001 to 2012: Historical cohort study. American Journal of Respiratory and Critical Care Medicine Conference: American Thoracic Society International Conference, ATS. 2015;191.

[95] C Ma, LC Gunaratnam, A Ericson, AL Conroy, S Namasopo, and RO Opoka. Handheld Point-of-Care Lactate Measurement at Admission Predicts Mortality in Ugandan Children Hospitalized with Pneumonia: A Prospective Cohort Study. Am J Trop Med Hyg. 2019;100:37-42. DOI: 10.4269/ajtmh.18-0344. [PMID:30398141]

[96] L MacphersonM OgeroS AkechJ AluvaalaD GatharaG IrimuRisk factors for death among children aged 5-14 years hospitalised with pneumonia: a retrospective cohort study in Kenya. BMJ Glob Health. 2019;4:e001715. DOI: 10.1136/bmjgh-2019-001715

[97] JL Mathew, S Singhi, P Ray, E Hagel, S Saghafian-Hedengren, and A Bansal. Etiology of community acquired pneumonia among children in India: prospective, cohort study. J Glob Health. 2015;5:050418. DOI: 10.7189/jogh.05.020418. [PMID:26528392]

[98] ED McCollum, T Mvalo, M Eckerle, AG Smith, D Kondowe, and D Makonokaya. Bubble continuous positive airway pressure for children with high-risk conditions and severe pneumonia in Malawi: an open label, randomised, controlled trial. Lancet Respir Med. 2019;7:964-74. DOI: 10.1016/S2213-2600(19)30243-7. [PMID:31562059]

[99] ED McCollum, DE Park, NL Watson, NSS Fancourt, C Focht, and HC Baggett. Digital auscultation in PERCH: Associations with chest radiography and pneumonia mortality in children. Pediatr Pulmonol. 2020;55:3197-3208. DOI: 10.1002/ppul.25046. [PMID:32852888]

[100] B Meligy, A Sayed, DK Ismail, D Kamal, W Abdel-Latif, and DM Erfan. Detection of viral acute lower respiratory tract infection in hospitalized infants using real-time PCR. Gaz Egypt Paediatr Assoc. 2016;64:13-9. DOI: 10.1016/j.epag.2015.11.005. [PMID:32288487]

[101] JG Mildemberger, GS Marcusso, and DC Chong-Silva. Social, demographic and etiological profile of severe pneumonia in a pediatric service. Pediatr Pulmonol. 2017;52:Suppl 46S140-1.

[102] GB Mohamed, MA Saed, AA Abdelhakeem, K Salah, and AM Saed. Predictive value of copeptin as a severity marker of community-acquired pneumonia. Electron Physician. 2017;9:4880-5. Electronic ResourceDOI: 10.19082/4880. [PMID:28894549]

[103] BM Morrow, CM Samuel, M Zampoli, A Whitelaw, and HJ Zar. Pneumocystis pneumonia in South African children diagnosed by molecular methods. BMC Res Notes. 2014;7:26 DOI: 10.1186/1756-0500-7-26. [PMID:24410938]

[104] PP Moschovis, EO Addo-Yobo, S Banajeh, N Chisaka, DC Christiani, and D Hayden. Stunting is associated with poor outcomes in childhood pneumonia. Trop Med Int Health. 2015;20:1320-8. DOI: 10.1111/tmi.12557. [PMID:26083963]

[105] PP Moschovis, S Banajeh, WB MacLeod, S Saha, D Hayden, and DC Christiani. Childhood anemia at high altitude: risk factors for poor outcomes in severe pneumonia. Pediatrics. 2013;132:e1156-62. DOI: 10.1542/peds.2013-0761. [PMID:24101768]

[106] S Myers, P Dinga, M Anderson, C Schubert, R Mlotha, and A Phiri. Use of bubble continuous positive airway pressure (bCPAP) in the management of critically ill children in a Malawian paediatric unit: an observational study. BMJ Open Respir Res. 2019;6:e000280. DOI: 10.1136/bmjresp-2018-000280. [PMID:30956794]

[107] A Naheed, RF Breiman, MS Islam, SK Saha, and R Tabassum Naved. Disparities by sex in care-seeking behaviors and treatment outcomes for pneumonia among children admitted to hospitals in Bangladesh. PLoS One. 2019;14:e0213238. DOI: 10.1371/journal.pone.0213238. [PMID:30845206]

[108] R Nantanda, MS Ostergaard, G Ndeezi, and JK Tumwine. Clinical outcomes of children with acute asthma and pneumonia in Mulago hospital, Uganda: a prospective study. BMC Pediatr. 2014;14:285 DOI: 10.1186/s12887-014-0285-4. [PMID:25431036]

[109] AM Nathan, F Rani, RJ Lee, R Zaki, C Westerhout, and IC Sam. Clinical risk factors for life-threatening lower respiratory tract infections in children: a retrospective study in an urban city in Malaysia. PLoS One. 2014;9:e111162. DOI: 10.1371/journal.pone.0111162. [PMID:25360811]

[110] AA NegashD AsratW AbebeT HailemariamT HailuA AseffaBacteremic Community-Acquired Pneumonia in Ethiopian Children: Etiology, Antibiotic Resistance, Risk Factors, and Clinical Outcome. Open Forum Infect Dis. 2019;6:ofz029. DOI: 10.1093/ofid/ofz029

[111] T Nemani and S Awasthi. Malnutrition and anaemia associated with hypoxia among hospitalized children with community-acquired pneumonia in North India. Clin Epidemiol Glob Health. 2016;4:S17-21. DOI: 10.1016/j.cegh.2016.08.011

[112] PTK NguyenHT TranDA FitzgeraldTS TranSM GrahamBJ MaraisCharacterisation of children hospitalised with pneumonia in central Vietnam: a prospective study. Eur Respir J. 2019;54:1802256. DOI: 10.1183/13993003.02256-2018

[113] K Nimdet and W Techakehakij. Congestive heart failure in children with pneumonia and respiratory failure. Pediatr Int. 2017;59:258-64. DOI: 10.1111/ped.13153. [PMID:27589216]

[114] C O’Callaghan-Gordo, Q Bassat, L Morais, N Diez-Padrisa, S Machevo, and T Nhampossa. Etiology and epidemiology of viral pneumonia among hospitalized children in rural Mozambique: a malaria endemic area with high prevalence of human immunodeficiency virus. Pediatr Infect Dis J. 2011;30:39-44. DOI: 10.1097/INF.0b013e3181f232fe. [PMID:20805786]

[115] G OfmanB PradarelliMT CaballeroA BianchiLA GrimaldiA SancilioRespiratory failure and death in vulnerable premature children with lower respiratory tract illness. J Infect Dis. 2020;222:1129-1137. DOI: 10.1093/infdis/jiaa046

[116] SJ Olsen, S Thamthitiwat, S Chantra, M Chittaganpitch, AM Fry, and JM Simmerman. Incidence of respiratory pathogens in persons hospitalized with pneumonia in two provinces in Thailand. Epidemiol Infect. 2010;138:1811-22. DOI: 10.1017/S0950268810000646. [PMID:20353622]

[117] CO Onyango, R Njeru, S Kazungu, R Achilla, W Bulimo, and SR Welch. Influenza surveillance among children with pneumonia admitted to a district hospital in coastal Kenya, 2007-2010. J Infect Dis. 2012;206:S61-7. DOI: 10.1093/infdis/jis536. [PMID:23169974]

[118] AE Orimadegun, BO Ogunbosi, and SS Carson. Prevalence and predictors of hypoxaemia in respiratory and non-respiratory primary diagnoses among emergently ill children at a tertiary hospital in south western Nigeria. Trans R Soc Trop Med Hyg. 2013;107:699-705. DOI: 10.1093/trstmh/trt082. [PMID:24062524]

[119] R Pagano, MO Wiens, B Shadgan, N Lowlaavar, G Napoleone, and GA Dumont. An observational study of peripheral muscle oxygenation using nirs in a cohort of nourished and malnourished children with pneumonia. Anesth Analg. 2018;127:1Suppl 194-5.

[120] M Pale, A Nacoto, A Tivane, N Nguenha, L Machalele, and F Gundane. Respiratory syncytial and influenza viruses in children under 2 years old with severe acute respiratory infection (SARI) in Maputo, 2015. PLoS One. 2017;12:e0186735. DOI: 10.1371/journal.pone.0186735. [PMID:29190684]

[121] AM Pedraza-Bernal, CE Rodriguez-Martinez, and R Acuna-Cordero. Predictors of severe disease in a hospitalized population of children with acute viral lower respiratory tract infections. J Med Virol. 2016;88:754-9. DOI: 10.1002/jmv.24394. [PMID:26403374]

[122] F Pulsan, K Sobi, and T Duke. Continuous positive airway pressure in children with severe pneumonia and hypoxaemia in Papua New Guinea: an evaluation of implementation. Acta Paediatr. 2019;108:1887-95. DOI: 10.1111/apa.14796. [PMID:30924962]

[123] S Rajatonirina, NH Razanajatovo, EH Ratsima, A Orelle, R Ratovoson, and ZZ Andrianirina. Outcome risk factors during respiratory infections in a paediatric ward in Antananarivo, Madagascar 2010-2012. PLoS One. 2013;8:e72839. DOI: 10.1371/journal.pone.0072839. [PMID:24069161]

[124] P Ramachandran, K Nedunchelian, A Vengatesan, and S Suresh. Risk factors for mortality in community acquired pneumonia among children aged 1-59 months admitted in a referral hospital. Indian Pediatr. 2012;49:889-95. DOI: 10.1007/s13312-012-0221-3. [PMID:22791667]

[125] B Ramakrishna, SM Graham, A Phiri, L Mankhambo, and T Duke. Lactate as a predictor of mortality in Malawian children with WHO-defined pneumonia. Arch Dis Child. 2012;97:336-42. DOI: 10.1136/archdischild-2011-300920. [PMID:22267369]

[126] C Reed, SA Madhi, KP Klugman, L Kuwanda, JR Ortiz, and L Finelli. Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa. PLoS One. 2012;7:e27793. DOI: 10.1371/journal.pone.0027793. [PMID:22238570]

[127] Rose K, Bezerra P, Duarte C, Britto M, Fonceca A, Hopkins M, et al. Viral causes of acute respiratory infection in pre-school children. American Journal of Respiratory and Critical Care Medicine Conference: American Thoracic Society International Conference, ATS. 2010;181.

[128] S Saghafian-Hedengren, JL Mathew, E Hagel, S Singhi, P Ray, and S Ygberg. Assessment of Cytokine and Chemokine Signatures as Potential Biomarkers of Childhood Community-acquired Pneumonia Severity: A Nested Cohort Study in India. Pediatr Infect Dis J. 2017;36:102-8. DOI: 10.1097/INF.0000000000001364. [PMID:27956727]

[129] S Saha, M Hasan, L Kim, JL Farrar, B Hossain, and M Islam. Epidemiology and risk factors for pneumonia severity and mortality in Bangladeshi children <5 years of age before 10-valent pneumococcal conjugate vaccine introduction. BMC Public Health. 2016;16:1233 DOI: 10.1186/s12889-016-3897-9. [PMID:27927201]

[130] NY Saleh and WMM Abo El Fotoh. Low serum zinc level: The relationship with severe pneumonia and survival in critically ill children. Int J Clin Pract. 2018;72:e13211. DOI: 10.1111/ijcp.13211. [PMID:29855123]

[131] W Shan, T Shi, K Chen, J Xue, Y Wang, and J Yu. Risk Factors for Severe Community-aquired Pneumonia Among Children Hospitalized With CAP Younger Than 5 Years of Age. Pediatr Infect Dis J. 2019;38:224-9. DOI: 10.1097/INF.0000000000002098. [PMID:29746377]

[132] C Solis-Chaves, DC Ortega-Saborio, G Loria-Chavarria, A Solis-Moya, A Yock-Corrales, and ME Soto-Quiros. Risk factors of severe community acquired pneumonia among children aged 2 and 59 months admitted to the national Children’s Hospital in Costa Rica. Pediatr Pulmonol. 2018;53:Suppl 1S119-20.

[133] MG Srinivasan, G Ndeezi, CK Mboijana, S Kiguli, GS Bimenya, and V Nankabirwa. Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: a randomized double blind placebo-controlled trial. BMC Med. 2012;10:14 DOI: 10.1186/1741-7015-10-14. [PMID:22316073]

[134] SS Sudarwati. Etiology and outcome of lower respiratory tract infection in children. Pediatr Pulmonol. 2014;49:S83-4.

[135] P Suntarattiwong, K Sojisirikul, P Sitaposa, A Pornpatanangkoon, M Chittaganpitch, and S Srijuntongsiri. Clinical and epidemiological characteristics of respiratory syncytial virus and influenza virus associated hospitalization in urban Thai infants. J Med Assoc Thai. 2011;94:Suppl 3S164-71. [PMID:22043771]

[136] CG Sutcliffe, DM Thea, P Seidenberg, J Chipeta, L Mwananyanda, and SW Somwe. A clinical guidance tool to improve the care of children hospitalized with severe pneumonia in Lusaka, Zambia. BMC Pediatr. 2016;16:136 DOI: 10.1186/s12887-016-0665-z. [PMID:27542355]

[137] A Suzuki, S Lupisan, Y Furuse, N Fuji, M Saito, and R Tamaki. Respiratory viruses from hospitalized children with severe pneumonia in the Philippines. BMC Infect Dis. 2012;12:267 DOI: 10.1186/1471-2334-12-267. [PMID:23092190]

[138] A Tapısız, H Ozdemir, E Ciftci, N Belet, E Ince, and U Dogru. Ampicillin/sulbactam for children hospitalized with community-acquired pneumonia. J Infect Chemother. 2011;17:504-9. DOI: 10.1007/s10156-011-0208-3. [PMID:21258955]

[139] S Tomczyk, JP McCracken, CL Contreras, MR Lopez, C Bernart, and JC Moir. Factors associated with fatal cases of acute respiratory infection (ARI) among hospitalized patients in Guatemala. BMC Public Health. 2019;19:499 DOI: 10.1186/s12889-019-6824-z. [PMID:31053069]

[140] T Tuti, A Agweyu, P Mwaniki, N Peek, and M English. Clinical Information Network Author G. An exploration of mortality risk factors in non-severe pneumonia in children using clinical data from Kenya. BMC Med. 2017;15:201 DOI: 10.1186/s12916-017-0963-9. [PMID:29129186]

[141] J Walk, P Dinga, C Banda, T Msiska, E Chitsamba, and N Chiwayula. Non-invasive ventilation with bubble CPAP is feasible and improves respiratory physiology in hospitalised Malawian children with acute respiratory failure. Paediatr Int Child Health. 2016;36:28-33. DOI: 10.1179/2046905514Y.0000000166. [PMID:25434361]

[142] G Wandeler, JY Pauchard, E Zangger, H Diawara, and M Gehri. Which clinical signs predict hypoxaemia in young Senegalese children with acute lower respiratory tract disease? Paediatr Int Child Health. 2015;35:65-8. DOI: 10.1179/2046905514Y.0000000153. [PMID:25547179]

[143] C Webb, M Ngama, A Ngatia, M Shebbe, S Morpeth, and S Mwarumba. Treatment failure among Kenyan children with severe pneumonia–a cohort study. Pediatr Infect Dis J. 2012;31:e152-7. DOI: 10.1097/INF.0b013e3182638012. [PMID:22692700]

[144] PT Wilson, F Baiden, JC Brooks, MC Morris, K Giessler, and D Punguyire. Continuous positive airway pressure for children with undifferentiated respiratory distress in Ghana: an open-label, cluster, crossover trial. Lancet Glob Health. 2017;5:e615-23. DOI: 10.1016/S2214-109X(17)30145-6. [PMID:28495265]

[145] R Zabihullah, BG Dhoubhadel, FA Rauf, SA Shafiq, M Suzuki, and K Watanabe. Risk for Death among Children with Pneumonia, Afghanistan. Emerg Infect Dis. 2017;23:1404-8. DOI: 10.3201/eid2308.151550. [PMID:28726625]

[146] M Zampoli, B Morrow, NY Hsiao, A Whitelaw, and HJ Zar. Prevalence and outcome of cytomegalovirus-associated pneumonia in relation to human immunodeficiency virus infection. Pediatr Infect Dis J. 2011;30:413-7. DOI: 10.1097/INF.0b013e3182065197. [PMID:21150691]

[147] A Zeeshan, Q Abbas, and A Kabir. Epidemiology and Outcomes of Critical Illness Caused by Community-Acquired Pneumonia in a Picu of a Low Middle Income Country. Chest. 2020;157:6SupplA83 DOI: 10.1016/j.chest.2020.05.092

[148] Q Zhang, Z Guo, Z Bai, and NEA MacDonald. 4 year prospective study to determine risk factors for severe community acquired pneumonia in children in southern China. Pediatr Pulmonol. 2013;48:390-7. DOI: 10.1002/ppul.22608. [PMID:22778084]

[149] Q Zhang, Z Guo, and NE MacDonald. Vaccine preventable community-acquired pneumonia in hospitalized children in Northwest China. Pediatr Infect Dis J. 2011;30:7-10. DOI: 10.1097/INF.0b013e3181ec6245. [PMID:20625346]

[150] R Zhang, U Rai, NBM Ibrahim, Y Amazouz, J Soo, and AL Conroy. Dysregulation of angiopoietin-Tie-2 axis in ugandan children hospitalized with pneumonia. Cytokine. 2020;133:155175. DOI: 10.1016/j.cyto.2020.155175. [PMID:32599540]

[151] YF Zhu, F Xu, XL Lu, Y Wang, JL Chen, and JX Chao. Mortality and morbidity of acute hypoxemic respiratory failure and acute respiratory distress syndrome in infants and young children. Chin Med J (Engl). 2012;125:2265-71. [PMID:22882846]

[152] HE Zidan, RM Elbehedy, and SF Azab. IL6-174 G/C gene polymorphism and its relation to serum IL6 in Egyptian children with community-acquired pneumonia. Cytokine. 2014;67:60-4. DOI: 10.1016/j.cyto.2014.02.013. [PMID:24725540]

[153] JN Zurita-Cruz, A Gutierrez-Gonzalez, L Manuel-Apolinar, JE Fernandez-Garate, ML Arellano-Flores, and RA Correa Gonzalez. Hospitalizations for viral respiratory infections in children under 2 years of age: epidemiology and in-hospital complications. BMC Pediatr. 2020;20:285 DOI: 10.1186/s12887-020-02186-7. [PMID:32517775]

[154] M Sonego, MC Pellegrin, M Becker, and M Lazzerini. Risk Factors for Mortality from Acute Lower Respiratory Infections (ALRI) in Children under Five Years of Age in Low and Middle-Income Countries: A Systematic Review and Meta-Analysis of Observational Studies. PLoS One. 2015;10:e0116380. DOI: 10.1371/journal.pone.0116380. [PMID:25635911]

[155] M Lazzerini, M Sonego, and MC Pellegrin. Hypoxaemia as a Mortality Risk Factor in Acute Lower Respiratory Infections in Children in Low and Middle-Income Countries: Systematic Review and Meta-Analysis. PLoS One. 2015;10:e0136166. DOI: 10.1371/journal.pone.0136166. [PMID:26372640]

[156] WHO/UNICEF. Ending Preventable Child Deaths from Pneumonia and Diarrhoea by 2025: The integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD). Geneva, Switzerland: World Health Organization (WHO); 2013.

[157] H Graham, M Tokhi, and T Duke. Scoping review: strategies of providing care for children with chronic health conditions in low- and middle-income countries. Trop Med Int Health. 2016;21:1366-88. DOI: 10.1111/tmi.12774. [PMID:27554327]

[158] Y Arai, H Shoji, K Awata, E Inage, T Ikuse, and T Shimizu. Evaluation of the use of non-invasive hemoglobin measurement in early childhood. Pediatr Res. 2022;DOI: 10.1038/s41390-022-02204-7. [PMID:35906313]

[159] H Graham, AA Bakare, AI Ayede, OB Oyewole, A Gray, and E Neal. Diagnosis of pneumonia and malaria in Nigerian hospitals: A prospective cohort study. Pediatr Pulmonol. 2020;55:S37-50. DOI: 10.1002/ppul.24691. [PMID:32074408]

Correspondence to:
Hamish Graham
University of Melbourne Department of Paediatrics,
The Royal Children’s Hospital Melbourne,
5 Flemington Road, Parkville, Victoria
[email protected]